Literature DB >> 21830269

Potential role for SNAIL family transcription factors in the etiology of Crohn's disease-associated fistulae.

Michael Scharl1, Achim Weber, Alois Fürst, Stefan Farkas, Ekkehard Jehle, Theresa Pesch, Silvia Kellermeier, Michael Fried, Gerhard Rogler.   

Abstract

BACKGROUND: Fistulae represent an important clinical complication of Crohn's disease (CD). The fistula tracts are covered by flat, myofibroblast-like cells with an epithelial origin (transitional cells, TC). We recently demonstrated a role of epithelial mesenchymal transition (EMT) in the pathogenesis of CD-associated fistulae. EMT is associated with an increased migratory and invasive potential of epithelial cells in different tissues. Here we investigated whether cytokines or growth factors as well as EMT-associated SNAIL family transcription factors are expressed in CD fistulae.
METHODS: By immunohistochemistry we analyzed seven perianal fistulae from seven CD and two perianal fistulae from two non-inflammatory bowel disease (IBD) control patients. Hematoxylin and eosin staining or immunohistochemistry for the expression of tumor necrosis factor (TNF), TNF-receptor I (TNF-RI), SNAIL1, SLUG, fibroblast growth factors (FGF) 1, 2, 4, 7, epidermal growth factor (EGF), and TWIST were performed using standard techniques.
RESULTS: Immunohistochemical staining of surgical specimens from CD patients revealed a strong expression of TNF and TNF-RI in and around fistula tracts. While SNAIL1 was also heavily expressed in the nuclei of TC, indicative of transcriptionally active protein, SLUG, FGF-1, and FGF-2 were detected rather in the fibrotic periphery of CD fistulae than in TC. In contrast, we did not detect considerable protein staining for FGF-4 and FGF-7 nor of EGF or the transcription factor, TWIST.
CONCLUSIONS: Our data demonstrate that SNAIL1 and TNF are strongly expressed in TC of CD-associated fistulae. These observations support our previous data and indicate the onset of EMT-associated events in the pathogenesis of CD fistulae.
Copyright © 2010 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21830269     DOI: 10.1002/ibd.21555

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  25 in total

1.  miR-130a and miR-212 Disrupt the Intestinal Epithelial Barrier through Modulation of PPARγ and Occludin Expression in Chronic Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Vinay Kumar; Joshua Mansfield; Rong Fan; Andrew MacLean; Jian Li; Mahesh Mohan
Journal:  J Immunol       Date:  2018-03-07       Impact factor: 5.422

Review 2.  The multifaceted mast cell in inflammatory bowel disease.

Authors:  Matthew J Hamilton; Sandra M Frei; Richard L Stevens
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 3.  The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel disease.

Authors:  Michael Scharl; Ramona S Bruckner; Gerhard Rogler
Journal:  United European Gastroenterol J       Date:  2016-02-19       Impact factor: 4.623

4.  Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease.

Authors:  Britta Siegmund; Roger M Feakins; Giorgos Barmias; Juliano Coelho Ludvig; Fabio Vieira Teixeira; Gerhard Rogler; Michael Scharl
Journal:  J Crohns Colitis       Date:  2015-12-17       Impact factor: 9.071

Review 5.  Pathophysiology of fistula formation in Crohn's disease.

Authors:  Michael Scharl; Gerhard Rogler
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 6.  Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy.

Authors:  Julián Panés; Jordi Rimola
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-09       Impact factor: 46.802

Review 7.  Epithelial-mesenchymal transition in Crohn's disease.

Authors:  H Jiang; J Shen; Z Ran
Journal:  Mucosal Immunol       Date:  2017-12-20       Impact factor: 7.313

8.  Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease Cohort.

Authors:  Jonas Zeitz; Nicolas Fournier; Christian Labenz; Luc Biedermann; Pascal Frei; Benjamin Misselwitz; Sylvie Scharl; Stephan R Vavricka; Michael C Sulz; Michael Fried; Gerhard Rogler; Michael Scharl
Journal:  Inflamm Intest Dis       Date:  2017-02-25

9.  Eribulin Does Not Prevent Epithelial-to-Mesenchymal Transition in HT-29 Intestinal Epithelial Cells.

Authors:  Martin Leutenegger; Ramona Bruckner; Marianne R Spalinger; Silvia Lang; Gerhard Rogler; Michael Scharl
Journal:  Inflamm Intest Dis       Date:  2018-07-10

Review 10.  Evaluation of animal models of Crohn's disease with anal fistula (Review).

Authors:  Shuangshuang Lu; Keyuan Zhu; Yongxin Guo; Enjing Wang; Jin Huang
Journal:  Exp Ther Med       Date:  2021-07-08       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.